Open AccessTreatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the Literature
Author(s) -
Kierstin Utter,
Chloe Goldman,
Sarah A. Weiss,
Richard L. Shapiro,
Russell S. Berman,
Melissa Wilson,
Anna C. Pavlick,
Iman Osman
Publication year - 2017
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000478050
Subject(s) - medicine , melanoma , clinical trial , oncology , systemic therapy , immunotherapy , population , metastatic melanoma , targeted therapy , surgery , cancer , environmental health , cancer research , breast cancer
Metastatic melanoma of unknown primary (MUP) is uncommon, biologically ill defined, and clinically understudied. MUP outcomes are seldom reported in clinical trials. In this study, we analyze responses of MUP patients treated with systemic therapy in an attempt to inform treatment guidelines for this unique population.